A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer. (Q48031013)
Jump to navigation
Jump to search
scientific article published in May 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer. |
scientific article published in May 2012 |
Statements
1 reference
A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer. (English)
1 reference
M N Levine
1 reference
C Gu
1 reference
H A Liebman
1 reference
C P Escalante
1 reference
S Solymoss
1 reference
D Deitchman
1 reference
L Ramirez
1 reference
J Julian
1 reference
1 May 2012
1 reference
10
1 reference
807-814
1 reference
5
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference